Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Sell
22,000
-3,000
-12% -$351K ﹤0.01% 273
2026
Q1
$3.01M Buy
+25,000
New +$2.89M 0.01% 268
2024
Q4
Sell
-52,400
Closed -$5.95M 333
2024
Q3
$5.95M Sell
52,400
-37,600
-42% -$4.47M 0.02% 256
2024
Q2
$11.1M Hold
90,000
0.03% 235
2024
Q1
$11.9M Buy
90,000
+2,600
+3% +$320K 0.03% 234
2023
Q4
$9.53M Hold
87,400
0.03% 236
2023
Q3
$9M Hold
87,400
0.03% 238
2023
Q2
$10.1M Buy
87,400
+12,100
+16% +$1.37M 0.03% 233
2023
Q1
$8.01M Buy
75,300
+5,000
+7% +$540K 0.02% 239
2022
Q4
$7.8M Buy
70,300
+15,800
+29% +$1.62M 0.03% 241
2022
Q3
$4.69M Buy
54,500
+7,200
+15% +$643K 0.02% 274
2022
Q2
$4.31M Buy
47,300
+18,000
+61% +$1.6M 0.01% 293
2022
Q1
$2.4M Buy
+29,300
New +$2.31M 0.01% 333
2020
Q1
Sell
-11,254
Closed -$977K 350
2019
Q4
$977K Buy
11,254
+3,486
+45% +$286K ﹤0.01% 293
2019
Q3
$624K Buy
7,768
+3,780
+95% +$303K ﹤0.01% 299
2019
Q2
$319K Buy
+3,988
New +$305K ﹤0.01% 316

Other funds holding MRK

BAMCO Inc's MRK Position: Q2 2026 in Review

BAMCO Inc reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $351K and leaving 22,000 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #273.

BAMCO Inc first reported a position in MRK in Q2 2019 and has held it in 16 quarters since. The position peaked at $11.9M in Q1 2024. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BAMCO Inc held 22,000 shares of Merck worth $2.83M as of Q2 2026.
  • BAMCO Inc sold 3,000 Merck shares in Q2 2026, an estimated $351K.
  • Merck made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #273 holding.
  • BAMCO Inc first reported a position in Merck in Q2 2019 and has held it in 16 quarters since.
  • BAMCO Inc's Merck position peaked at $11.9M in Q1 2024.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.